Xuesong Ouyang

2.5k total citations
28 papers, 1.8k citations indexed

About

Xuesong Ouyang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuesong Ouyang has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuesong Ouyang's work include Prostate Cancer Treatment and Research (9 papers), Cancer-related Molecular Pathways (4 papers) and CAR-T cell therapy research (3 papers). Xuesong Ouyang is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Cancer-related Molecular Pathways (4 papers) and CAR-T cell therapy research (3 papers). Xuesong Ouyang collaborates with scholars based in United States, China and Canada. Xuesong Ouyang's co-authors include Cory Abate‐Shen, Hui Gao, Whitney Banach‐Petrosky, William L. Gerald, Michael M. Shen, Kexin Xu, Sai‐Wah Tsao, Xianghong Wang, Ming‐Tat Ling and Raphaël Margueron and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Xuesong Ouyang

27 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuesong Ouyang United States 18 1.3k 508 419 333 204 28 1.8k
Yunqian Pan United States 26 1.6k 1.2× 491 1.0× 457 1.1× 559 1.7× 120 0.6× 40 2.0k
June X. Zou United States 25 1.8k 1.4× 352 0.7× 472 1.1× 475 1.4× 367 1.8× 32 2.3k
Oona Delpuech United Kingdom 20 1.1k 0.8× 243 0.5× 433 1.0× 460 1.4× 79 0.4× 33 1.7k
Eiji Kashiwagi Japan 31 1.3k 1.0× 943 1.9× 628 1.5× 588 1.8× 295 1.4× 126 2.6k
Toshiyuki Sakamaki United States 19 2.1k 1.6× 315 0.6× 1.0k 2.4× 712 2.1× 300 1.5× 25 2.9k
Jing Ni United States 22 940 0.7× 378 0.7× 324 0.8× 282 0.8× 182 0.9× 37 1.7k
Bojie Dai United States 18 697 0.5× 264 0.5× 194 0.5× 193 0.6× 115 0.6× 30 1.1k
Ivana Sarotto Italy 25 808 0.6× 317 0.6× 885 2.1× 542 1.6× 112 0.5× 50 2.3k
Toshiro Migita Japan 25 1.6k 1.2× 449 0.9× 511 1.2× 1.0k 3.1× 116 0.6× 38 2.4k
Peter Buechler Germany 6 1.3k 1.0× 267 0.5× 621 1.5× 1.6k 4.8× 216 1.1× 10 2.4k

Countries citing papers authored by Xuesong Ouyang

Since Specialization
Citations

This map shows the geographic impact of Xuesong Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuesong Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuesong Ouyang more than expected).

Fields of papers citing papers by Xuesong Ouyang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuesong Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuesong Ouyang. The network helps show where Xuesong Ouyang may publish in the future.

Co-authorship network of co-authors of Xuesong Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuesong Ouyang. A scholar is included among the top collaborators of Xuesong Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuesong Ouyang. Xuesong Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Ying, Xiaoyu An, Binchen Mao, et al.. (2022). Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment. Scientific Reports. 12(1). 3278–3278. 40 indexed citations
2.
Kumari, Rajendra, Xuesong Ouyang, Jingjing Wang, et al.. (2021). Preclinical pharmacology modeling of chimeric antigen receptor T therapies. Current Opinion in Pharmacology. 61. 49–61. 17 indexed citations
3.
Xu, Xiaoxi, Philip Wang, Jun Zhou, et al.. (2021). Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research. Journal of Visualized Experiments. 7 indexed citations
4.
An, Xiaoyu, Xuesong Ouyang, Hui Zhang, et al.. (2018). Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry. Journal of Visualized Experiments. 5 indexed citations
5.
Li, Qi‐Xiang, Gerold Feuer, Xuesong Ouyang, & Xiaoyu An. (2017). Experimental animal modeling for immuno-oncology. Pharmacology & Therapeutics. 173. 34–46. 41 indexed citations
6.
Wu, Tingyu, Wei Chen, Yongwang Zhong, et al.. (2016). Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor. Molecular Cancer Therapeutics. 16(4). 717–728. 17 indexed citations
7.
Song, Lixin, Sherry Lu, Xuesong Ouyang, et al.. (2015). Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology. Molecular Neurodegeneration. 10(1). 14–14. 37 indexed citations
8.
Lin, Hua, Zhu Shen, Lei Zhu, et al.. (2013). Diacylglycerol Acyltransferase-1 (DGAT1) Inhibition Perturbs Postprandial Gut Hormone Release. PLoS ONE. 8(1). e54480–e54480. 10 indexed citations
9.
Castro‐Perez, José, Thomas P. Roddy, Vinit Shah, et al.. (2011). Attenuation of Slc27a5 Gene Expression Followed by LC–MS Measurement of Bile Acid Reconjugation Using Metabolomics and a Stable Isotope Tracer Strategy. Journal of Proteome Research. 10(10). 4683–4691. 5 indexed citations
10.
Ouyang, Xuesong, Walter J. Jessen, Hikmat Al‐Ahmadie, et al.. (2008). Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer. Cancer Research. 68(7). 2132–2144. 108 indexed citations
11.
Kinkade, Carolyn Waugh, Mireia Castillo-Martín, Anna M. Puzio‐Kuter, et al.. (2008). Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. Journal of Clinical Investigation. 118(9). 3051–64. 318 indexed citations
12.
Jeong, Joseph H., Zhenxiong Wang, Xuesong Ouyang, et al.. (2008). BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma. PLoS ONE. 3(12). e3949–e3949. 40 indexed citations
13.
Banach‐Petrosky, Whitney, Walter J. Jessen, Xuesong Ouyang, et al.. (2007). Prolonged Exposure to Reduced Levels of Androgen Accelerates Prostate Cancer Progression in Nkx3.1; Pten Mutant Mice. Cancer Research. 67(19). 9089–9096. 62 indexed citations
14.
Gao, Hui, Xuesong Ouyang, Whitney Banach‐Petrosky, Michael M. Shen, & Cory Abate‐Shen. (2006). Emergence of Androgen Independence at Early Stages of Prostate Cancer Progression in Nkx3.1; Pten Mice. Cancer Research. 66(16). 7929–7933. 72 indexed citations
15.
Gao, Hui, Xuesong Ouyang, Whitney Banach‐Petrosky, et al.. (2006). Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proceedings of the National Academy of Sciences. 103(39). 14477–14482. 107 indexed citations
16.
Ouyang, Xuesong, Theodore L. DeWeese, William G. Nelson, & Cory Abate‐Shen. (2005). Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis. Cancer Research. 65(15). 6773–6779. 117 indexed citations
17.
Sadlier, Denise M., Xuesong Ouyang, Blaithin A. McMahon, et al.. (2005). Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritis. Kidney International. 68(6). 2542–2561. 21 indexed citations
18.
Ling, Ming‐Tat, Xianghong Wang, Xuesong Ouyang, et al.. (2003). Id-1 expression promotes cell survival through activation of NF-κB signalling pathway in prostate cancer cells. Oncogene. 22(29). 4498–4508. 131 indexed citations
19.
Ling, Ming‐Tat, Xianghong Wang, Xuesong Ouyang, et al.. (2002). Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth. Oncogene. 21(55). 8498–8505. 83 indexed citations
20.
Ouyang, Xuesong, Xianghong Wang, Kexin Xu, et al.. (2001). Effect of p53 on centrosome amplification in prostate cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1541(3). 212–220. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunqian Pan Breakdown of academic impact, for papers by June X. Zou Breakdown of academic impact, for papers by Oona Delpuech Breakdown of academic impact, for papers by Eiji Kashiwagi Breakdown of academic impact, for papers by Toshiyuki Sakamaki Breakdown of academic impact, for papers by Jing Ni Breakdown of academic impact, for papers by Bojie Dai Breakdown of academic impact, for papers by Ivana Sarotto Breakdown of academic impact, for papers by Toshiro Migita Breakdown of academic impact, for papers by Peter Buechler
Rankless by CCL
2026